Loading...
Header Logo
Keywords
Last Name
Institution

OLAOLUWA OKUSAGA

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
DivisionPsychiatry & Behavioral Sciences
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Boozalis T, Devaraj S, Okusaga OO. Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia. Psychiatr Q. 2019 03; 90(1):101-110. PMID: 30315442.
      View in: PubMed
    2. Deng H, Desai PV, Mohite S, Okusaga OO, Zhang XY, Nielsen DA, Kosten TR. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users. J Stud Alcohol Drugs. 2019 Mar; 80(2):230-235. PMID: 31014468.
      View in: PubMed
    3. Wadhawan A, Stiller JW, Potocki E, Okusaga O, Dagdag A, Lowry CA, Benros ME, Postolache TT. Traumatic Brain Injury and Suicidal Behavior: A Review. J Alzheimers Dis. 2019; 68(4):1339-1370. PMID: 30909230.
      View in: PubMed
    4. Hamilton JE, Heads AM, Meyer TD, Desai PV, Okusaga OO, Cho RY. Ethnic differences in the diagnosis of schizophrenia and mood disorders during admission to an academic safety-net psychiatric hospital. Psychiatry Res. 2018 09; 267:160-167. PMID: 29908484.
      View in: PubMed
    5. Deng H, Kahlon RS, Mohite S, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Fries GR, Walss-Bass C, Soares JC, Okusaga OO. Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia. Psychiatr Q. 2018 03; 89(1):53-60. PMID: 28435992.
      View in: PubMed
    6. Boozalis T, Teixeira AL, Cho RY, Okusaga O. C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia. Front Public Health. 2017; 5:360. PMID: 29404313.
      View in: PubMed
    7. Deng H, Mohite S, Suchting R, Nielsen DA, Okusaga OO. Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. Psychiatry Res. 2018 03; 261:248-252. PMID: 29329043.
      View in: PubMed
    8. Okusaga OO. Trajectory of brain maturation and sex-specific cognitive abnormalities in early-onset psychosis. Braz J Psychiatry. 2017 Oct-Dec; 39(4):381. PMID: 29160529.
      View in: PubMed
    9. Mohite S, Yang F, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Sharma AN, Fries GR, Walss-Bass C, Soares JC, Okusaga OO. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls. PLoS One. 2017; 12(3):e0174073. PMID: 28334045.
      View in: PubMed
    10. Kimm TS, Okusaga OO, Schulz PE. Delirious Mania in Bipolar Disorder. Prim Care Companion CNS Disord. 2017 Mar 02; 19(2). PMID: 28257173.
      View in: PubMed
    11. Tangu K, Ifeanyi A, Velusamy M, Dar S, Shah N, Ezeobele IE, Okusaga OO. Knowledge and Attitude Towards Pharmacological Management of Acute Agitation: A Survey of Psychiatrists, Psychiatry Residents, and Psychiatric Nurses. Acad Psychiatry. 2017 Jun; 41(3):333-336. PMID: 27943131.
      View in: PubMed
    12. Babatope T, Chotalia J, Elkhatib R, Mohite S, Shah J, Goddu S, Patel RA, Aimienwanu OR, Patel D, Makanjuola T, Okusaga OO. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder. Psychiatr Q. 2016 12; 87(4):729-737. PMID: 26875104.
      View in: PubMed
    13. de Barros JLVM, Barbosa IG, Salem H, Rocha NP, Kummer A, Okusaga OO, Soares JC, Teixeira AL. Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J Affect Disord. 2017 Feb; 209:59-65. PMID: 27889597.
      View in: PubMed
    14. Okusaga O, Fuchs D, Reeves G, Giegling I, Hartmann AM, Konte B, Friedl M, Groer M, Cook TB, Stearns-Yoder KA, Pandey JP, Kelly DL, Hoisington AJ, Lowry CA, Eaton WW, Brenner LA, Rujescu D, Postolache TT. Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies. Psychosom Med. 2016 10; 78(8):931-939. PMID: 27359171.
      View in: PubMed
    15. Mathai AJ, Kanwar J, Okusaga O, Fuchs D, Lowry CA, Peng X, Giegling I, Hartmann AM, Konte B, Friedl M, Gragnoli C, Reeves GM, Groer MW, Rosenthal RN, Rujescu D, Postolache TT. Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia. Front Public Health. 2016; 4:182. PMID: 27626030.
      View in: PubMed
    16. Zhao Z, Okusaga OO, Quevedo J, Soares JC, Teixeira AL. The potential association between obesity and bipolar disorder: A meta-analysis. J Affect Disord. 2016 Sep 15; 202:120-3. PMID: 27262632.
      View in: PubMed
    17. Parsaik AK, Mascarenhas SS, Hashmi A, Prokop LJ, John V, Okusaga O, Singh B. Role of Botulinum Toxin in Depression. J Psychiatr Pract. 2016 03; 22(2):99-110. PMID: 27138078.
      View in: PubMed
    18. Parsaik AK, Mascarenhas SS, Khosh-Chashm D, Hashmi A, John V, Okusaga O, Singh B. Mortality associated with anxiolytic and hypnotic drugs-A systematic review and meta-analysis. Aust N Z J Psychiatry. 2016 Jun; 50(6):520-33. PMID: 26590022.
      View in: PubMed
    19. Okusaga O, Duncan E, Langenberg P, Brundin L, Fuchs D, Groer MW, Giegling I, Stearns-Yoder KA, Hartmann AM, Konte B, Friedl M, Brenner LA, Lowry CA, Rujescu D, Postolache TT. Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophrenia. J Psychiatr Res. 2016 Jan; 72:74-81. PMID: 26594873.
      View in: PubMed
    20. Wu HE, Okusaga OO. Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence. Psychiatr Q. 2015 Jun; 86(2):199-205. PMID: 25164199.
      View in: PubMed
    21. Mohite S, Ngana I, Okusaga OO. Cocaine use in individuals with schizophrenia: impact on doses of discharge antipsychotic medications. J Addict Med. 2015 May-Jun; 9(3):177-80. PMID: 25700142.
      View in: PubMed
    22. Wu HE, Mohite S, Ngana I, Burns W, Shah N, Schneider L, Schmitz JM, Lane SD, Okusaga OO. Hospital length of stay in individuals with schizophrenia with and without cocaine-positive urine drug screens at hospital admission. J Nerv Ment Dis. 2015 Jan; 203(1):33-6. PMID: 25489749.
      View in: PubMed
    23. Zhang XY, Chen DC, Tan YL, Tan SP, Wang ZR, Yang FD, Okusaga OO, Zunta-Soares GB, Soares JC. The interplay between BDNF and oxidative stress in chronic schizophrenia. Psychoneuroendocrinology. 2015 Jan; 51:201-8. PMID: 25462893.
      View in: PubMed
    24. Xiu MH, Yang GG, Tan YL, Chen DC, Tan SP, Wang ZR, Yang FD, Okusaga O, Soares JC, Zhang XY. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology. Schizophr Res. 2014 Jun; 156(1):9-14. PMID: 24766914.
      View in: PubMed
    25. Okusaga O, Hamilton RG, Can A, Igbide A, Giegling I, Hartmann AM, Konte B, Friedl M, Reeves GM, Rujescu D, Postolache TT. Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study. AIMS Public Health. 2014 Mar 24; 1(2):43-50. PMID: 25346942.
      View in: PubMed
    26. Okusaga O, Muravitskaja O, Fuchs D, Ashraf A, Hinman S, Giegling I, Hartmann AM, Konte B, Friedl M, Schiffman J, Hong E, Reeves G, Groer M, Dantzer R, Rujescu D, Postolache TT. Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? PLoS One. 2014; 9(1):e85945. PMID: 24465804.
      View in: PubMed
    27. Okusaga OO. 6R-l-erythro-5,6,7,8-tetrahydrobiopterin (BH4): a potential treatment for all symptom domains of schizophrenia. Med Hypotheses. 2014 Mar; 82(3):395-7. PMID: 24491428.
      View in: PubMed
    28. Reeves GM, Mazaheri S, Snitker S, Langenberg P, Giegling I, Hartmann AM, Konte B, Friedl M, Okusaga O, Groer MW, Mangge H, Weghuber D, Allison DB, Rujescu D, Postolache TT. A Positive Association between T. gondii Seropositivity and Obesity. Front Public Health. 2013; 1:73. PMID: 24400300.
      View in: PubMed
    29. Okusaga OO. Accelerated aging in schizophrenia patients: the potential role of oxidative stress. Aging Dis. 2014 Aug; 5(4):256-62. PMID: 25110609.
      View in: PubMed
    30. Kanwar J, Okusaga O, Giegling I, Konte B, Vaswani D, Sleemi A, Vaswani R, Hartmann AM, Friedl M, Hong LE, Reeves G, Stephens S, Dixon L, Rujescu D, Postolache TT. In patients with schizophrenia, non-fatal suicidal self-directed violence is positively associated with present but not past smoking. Schizophr Res. 2013 Sep; 149(1-3):194-5. PMID: 23810528.
      View in: PubMed
    31. Okusaga O, Stewart MC, Butcher I, Deary I, Fowkes FG, Price JF. Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults. Age Ageing. 2013 May; 42(3):306-11. PMID: 23302603.
      View in: PubMed
    32. Okusaga O, Yolken RH, Langenberg P, Sleemi A, Kelly DL, Vaswani D, Giegling I, Hartmann AM, Konte B, Friedl M, Mohyuddin F, Groer MW, Rujescu D, Postolache TT. Elevated gliadin antibody levels in individuals with schizophrenia. World J Biol Psychiatry. 2013 Sep; 14(7):509-15. PMID: 23282016.
      View in: PubMed
    33. Zhang Y, Träskman-Bendz L, Janelidze S, Langenberg P, Saleh A, Constantine N, Okusaga O, Bay-Richter C, Brundin L, Postolache TT. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry. 2012 Aug; 73(8):1069-76. PMID: 22938818.
      View in: PubMed
    34. Woo JM, Okusaga O, Postolache TT. Seasonality of suicidal behavior. Int J Environ Res Public Health. 2012 02; 9(2):531-47. PMID: 22470308.
      View in: PubMed
    35. Sleemi A, Johnson MA, Rohan KJ, Okusaga O, Adediran T, Uzoma H, Walsh C, Reeves G, Postolache TT. Reading increases ocular illuminance during light treatment. Int J Adolesc Med Health. 2012; 24(4):339-42. PMID: 23183735.
      View in: PubMed
    36. Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, Konte B, Friedl M, Groer MW, Yolken RH, Rujescu D, Postolache TT. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res. 2011 Dec; 133(1-3):150-5. PMID: 21890329.
      View in: PubMed
    37. Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB, Scrandis DA, Severance E, Cabassa JA, Balis T, Postolache TT. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J Affect Disord. 2011 Apr; 130(1-2):220-5. PMID: 21030090.
      View in: PubMed
    OKUSAGA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description